MAP2K7 and melanoma: Thus, while previous studies showed a correlation between DUSP4 expression and MEK inhibitor sensitivity in pan-tumour cell line panels,53 we report for the first time that this association exists in clinical melanomas, and depleting DUSP4 expression induces resistance to MEK inhibition.